Teaming with Massachusetts General Hospital and others, J&J’s Veridex is developing a novel method of isolating cancer cells from a patient’s bloodstream. If successful, the blood test could ultimately replace more invasive and…
Prestigious management consulting firm McKinsey & Co. just published Value: The Four Cornerstones of Corporate Finance, a guide to help executives create shareholder value. Lead author Tim Koller shares his thoughts with DailyF…
The conglomerate said Tuesday that it plans to invest more than $2 billion in China through 2012 in research and development, technology and financial services partnerships. The move marks GE’s “confidence in China’s long-term …
Corporate America took a tightfisted approach to its future last year, leading to an overall 3.5% decline in research and development spending at major industry titans, the first such drop in over a decade, according to a Booz …
Swiss pharmaceutical company Novartis announced Tuesday that it had discontinued the development of two drugs — the hepatitis C treatment Zalbin, and antifungal agent Mycograb. The company will take impairment charges of appro…